Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such a disease means that the comorbidities associated with COPD should be taken into account in both diagnosis and treatment. First and foremost, cardiovascular comorbidities should be mentioned. In the advanced stage, osteoporosis and muscle hypotrophy are important comorbidities that should be addressed.
Autoren
- PD Dr. med. Sebastian Fähndrich
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Pulmonary hypertension
PH and lung diseases
- COPD therapy
Drug therapy – Update 2025
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Focus on prevention
Colorectal cancer screening – an update
- Chronic hand eczema
Topical pan-JAK-i vs. systemic retinoid: head-to-head study
- Study report
Long-term data on CFTR modulators in children with cystic fibrosis
- Multiple sclerosis
Multiple sclerosis 2025: New strategies against progression and the role of microglia
- A syndrome between decompensation and chronification